{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:07:34Z","timestamp":1753891654282,"version":"3.41.2"},"reference-count":14,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:p>Cardiovascular diseases are a leading cause of mortality in Saudi Arabia, accounting for approximately 42% of deaths. The \u201ctriple whammy\u201d phenomenon\u2014which combines angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, diuretics, and non-steroidal anti-inflammatory drugs\u2014increases the risk of acute kidney injury, particularly in hypertensive patients. This study, which was conducted in small-scale hospitals in Jeddah from 2017 to 2022, assessed the incidence of the triple whammy phenomenon and the awareness of healthcare professionals of this condition. Of 5,654 patient records, 1,899 met the inclusion criteria, with 2.7% experiencing the triple whammy. A survey of 56 healthcare professionals revealed 75% unawareness, with pharmacists and dentists being the most affected. Access to over-the-counter non-steroidal anti-inflammatory drugs and gaps in training likely drive the incidence and awareness deficits. This phenomenon can lead to acute kidney injury, with mortality rates as high as 50%\u201380% in critically ill patients, and imposes significant costs, representing 5% of hospital budgets and 1% of the overall health expenditure. Interventions including education, pharmacist roles, and non-steroidal anti-inflammatory drug regulation are proposed. Limitations include the small-scale focus and the low survey sample, necessitating national studies to accurately measure incidence and to improve patient safety.<\/jats:p>","DOI":"10.3389\/fneph.2025.1494459","type":"journal-article","created":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:10:36Z","timestamp":1748319036000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence of the Triple Whammy Phenomenon among Cardiovascular diseases patients in Saudi Arabia and awareness among healthcare professionals"],"prefix":"10.3389","volume":"5","author":[{"given":"Mohammad Bonyan","family":"Alsobaie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lubna","family":"Alsheikh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"volume-title":"Global atlas on cardiovascular disease prevention and control","year":"2011","author":"Mendis","key":"B1"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2000.tb125548.x","article-title":"Diuretics, ACE inhibitors and NSAIDs\u2014the triple whammy","volume":"172","author":"Thomas","year":"2000","journal-title":"Med J Aust"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3109\/0886022X.2014.917943","article-title":"More on the \u2018Triple Whammy\u2019: antihypertensive drugs, NSAIDs, and AKI","volume":"36","author":"Fournier","year":"2014","journal-title":"Ren Fail"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2017.0306","article-title":"A comprehensive review of NSAID use in the elderly","volume":"9","author":"Wongrakpanich","year":"2018","journal-title":"Aging Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"crossref","DOI":"10.1179\/acb.2007.077","article-title":"Acute kidney injury, length of stay, and costs in patients hospitalized in the intensive care unit","author":"Vandijck","year":"2007","journal-title":"Acta Clin Belg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41440-024-01593-y","article-title":"Low on-treatment blood pressure and cardiovascular events in patients without elevated risk: a nationwide cohort study","volume":"47","author":"Mori","year":"2024","journal-title":"Hypertens Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S469376","article-title":"J-shaped relationship between weight-adjusted-waist index and cardiovascular disease risk in hypertensive patients with obstructive sleep apnea: A cohort study","volume":"17","author":"Zhao","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsps.2017.12.009","article-title":"Top 10 most used drugs in the Kingdom of Saudi Arabia 2010-2015","volume":"26","author":"AlKhamees","year":"2018","journal-title":"Saudi Pharm J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.sdentj.2024.02.003","article-title":"Papillon-Lef\u00e8vre syndrome in dental pediatric patient: A comprehensive review","volume":"36","author":"Raja Rajeswari","year":"2024","journal-title":"Saudi Dent J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e8525","article-title":"Concurrent use of diuretics, ACE inhibitors, ARBs, and NSAIDs: Risk of AKI","volume":"346","author":"Lapi","year":"2013","journal-title":"BMJ"},{"key":"B12","unstructured":"Clinical pharmacology in dentistry: 2025 update \u2013 Zoom webinar\n          \n          \n            \n              Skaar\n              D\n            \n          \n          \n          2025"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu016","article-title":"The economic impact of acute kidney injury in England","volume":"29","author":"Kerr","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"B14","unstructured":"Open data"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1494459\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T04:10:38Z","timestamp":1748319038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2025.1494459\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":14,"alternative-id":["10.3389\/fneph.2025.1494459"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2025.1494459","relation":{},"ISSN":["2813-0626"],"issn-type":[{"type":"electronic","value":"2813-0626"}],"subject":[],"published":{"date-parts":[[2025,5,27]]},"article-number":"1494459"}}